
    
      A Phase I, Single-centre, Open-label, Partly Randomised, Cross-over Single Dose Study in
      Healthy Volunteers to Evaluate the Absolute Pulmonary Bioavailability of AZD8683 when
      Administered Inhaled via a New Dry Powder Inhaler and via Turbuhalerâ„¢
    
  